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Volume 54, Number 4 Abstracts 1231Conclusions: Current CMS physiologic high-risk CEA criteria place
patients at increased risk for adverse events for CAS. This warrants the need
to reconsider patient selection criteria for CAS vs CEA in physiologically
high-risk patients.
Short-term Dietary Manipulations can Attenuate the Adipose Inflam-
matory Response to Surgical Trauma
Binh Nguyen, Peng Yu, Ming Tao, Godfrey Ilonzo, C. Keith Ozaki,
Brigham and Women’s Hospital, Boston, Mass
Introduction and objectives: Morbid obesity is frequently associated
with increased surgical morbidity and mortality, and adipose is increasingly
recognized as an organ that plays an important mechanistic role in host
inflammation. We thus hypothesized that diet-induced obesity drives an
accentuated proinflammatory adipose response to surgical trauma and that
short-term dietary intervention by switching from a high-fat diet to a normal
diet can attenuate this response.
Methods: Standard surgical manipulations were performed on the left
flank fat pad of 26-week-old C57Bl6 male mice fed normal chow for 20
weeks (n  6), high-fat chow for 20 weeks (60% Kcal; n  6), or high-fat
chow for 17 weeks reversed to normal chow for 3 weeks (n  6). Day 1
adipose was collected and the expression of the proinflammatory cytokines
interleukin (IL)-1, IL-6, and tumor necrosis factor(TNF)-, and of the
anti-inflammatory cytokine IL-10 was assessed using quantitative RT-PCR
(individually normalized to day 0 adipose).
Results: Expression of all assayed mediators was induced by surgical
trauma. Adipose from the group fed high-fat chow yielded an exaggerated
proinflammatory cytokine signature compared with controls fed normal
chow (P  .002 for IL-1a and IL-6). Short-term dietary reversal signifi-
cantly attenuated the IL-1 (P  .002) and IL-6 induction (P  .015).
Conclusion: Surgery induces proinflammatory and anti-inflammatory
cytokine expression, and diet-induced obesity is associated with an accentu-
ated proinflammatory cytokine response to surgical trauma. Short-term
dietary switch to a normal chow diet attenuates this response. These results
support a nimble adipose phenotype and suggest that periprocedural dietary
interventions could affect surgical outcomes (Fig).
A Novel Model of Hind Limb Ischemia to Test Human Therapeutic
Angiogenesis
Robert A. Brenes,1 Mackenzie Bear,2 Caroline Jadlowiec,2 Peter Hashim,2
Alan Dardik,2 1Saint Mary’s Hospital, Waterbury, Conn; 2Yale University
School of Medicine, New Haven, Conn
Introduction and objectives: Clinical trials injecting bone marrow-
derived mononuclear cells (MNC) for therapeutic angiogenesis in patients
with critical limb ischemia are currently underway. However, there are
limited animal models available that adequately model human disease to
allow direction of the human studies.
Methods:C57BL/6male mice (aged 6-8 weeks) underwent unilateral
high femoral artery ligation and excision; the contralateral leg was used as a
control. MNC were isolated from donor mice, suspended in Roswell Park
Memorial Institute 1640, and injected into the gastrocnemius. Control
Fig.injections used an equal volume of medium without cells. MNC were
characterized using fluorescence-activated cell-sorting analysis. Muscle
p
slood flow was measured with “deep probe” laser Doppler. Functional
arlov, ischemia, and modified ischemia scales were recorded at intervals
efore the operation and to 4 weeks after. Mice were euthanized at 1, 2, and
weeks for histologic analysis. Statistics were based on five random fields of
iew at original magnification 40.
Results: Blood flow was significantly higher in MNC-injected mice
han in controls (P .0001). Tarlov scores were statistically higher through-
ut the first week postoperatively in MNC mice (P  .0064). Ischemia
cores were significantly higher in MNCmice (P .0269). Average number
f muscle fibers was lower and fiber area was higher in MNCmice (n 3) at
ll intervals (P  .01).
Conclusions: High femoral ligation and excision is a reproducible
odel of limb ischemia in C57BL/6 mice that shows response to MNC
njection. These studies suggest several parameters of human trials can be
ested in a small animal model in a cost-effective manner, allowing optimi-
ation of human trial parameters.
itrosylative Stress During Ischemia–Reperfusion Injury: Implications
or Poly (Adenosine Diphosphate-Ribose) Polymerase and Nitric Ox-
de Synthase Activity
hirling Tsai, Chandler A. Long, Hyung-Jin Yoo, Rahmi Oklu, Michael T.
atkins, Hassan Albadawi, Massachusetts General Hospital, Boston, Mass
Introduction and objectives: Poly (adenosine diphosphate [ADP]-
ibose) polymerase (PARP) inhibition is cytoprotective during limb ischemia–
eperfusion (IR) injury. Paradoxically, PARP activation may be triggered by
ysfunctional nitric oxide synthase (NOS) activity. These experiments were
ndertaken to assess whether NOS inhibition will ameliorate skeletal muscle
njury and alter PARP activity during the acute and early chronic phases of
eperfusion in a mouse model of hind limb IR.
Methods: Two groups of C57BL6 mice were underwent to 1.5 hours
f hind limb ischemia, followed by reperfusion. Mice were treated with the
OS inhibitor NG-nitro-L-Arginine methyl ester (L-NAME, 50 mg/kg/d
 10) or normal saline (n  10) starting 1 day before IR. Hind limb
uscles were harvested after 1 day or 7 days of reperfusion for histologic
valuation of skeletal muscle fiber injury and protein expression. PARP
ctivity was assessed by Western blotting for poly-ADP-ribosylated (PAR)
roteins. NOS activity was evaluated by measuring tissue nitrite, the expres-
ion of total-nNOS and the activating pS1412 and the inhibitory pS847-
NOS sites. Evidence of nitrosative stress was estimated byWestern blotting
or nitrotyrosine. Data were analyzed by Student t test.
Results:L-NAME treatment resulted in an 80% increase in the number
f injured fibers compared with nitrotyrosine at day 1 IR (P  .02.) There
as no difference in PARP activity at days 1 or 7 between the two groups.
urthermore, there was no significant difference in nitrite, nitrotyrosine, or
he expression of total or pS1412-nNOS, but there was significantly less
S847-nNOS expression in the L-NAME group at day 7 (P  .0003).
Conclusions: L-NAME treatment exacerbates skeletal muscle fiber
njury after IR but does not alter PARP activity. Because NOS inhibition
pharmacologic and through phosphorylation) does not alter nitrite or
itrotyrosine levels after injury, NOS and interactions may be partially
OS-independent during acute IR.
Western blotting data are expressed as average specific bands densities 
tandard error. *P .001 compared with NS.
mall Interfering RNA Coating of Prosthetic Arterial Graft Materials
aggie Chun,1 Christoph S. Nabzdyk,1 Juila D. Glaser,1 Saif Pathan,2
atthew Phaneuf,2 Leena Pradhan,1 Frank W. LoGerfo,1 1Beth Israel
eaconess Medical Center, Boston, Mass; 2BioSurfaces, Inc, Ashland, Mass
Introduction and objectives: Intimal hyperplasia (IH) remains the
eading cause for prosthetic arterial graft failure. Electrospinning of the
acron-based polymer, polyethylene terephthalate (ePET), is an appealing
lternative to woven or knitted Dacron or polytetrafluoroethylene (PTFE)
rafts. RNA interference is a promising tool to silence genes contributing to
H. Combining these technologies thus seemed logical. In this study, ePET
nd commercially available PTFE fabrics were dipped into various small
nterfering (si) RNA formulations, and adsorption of siRNA to the materials
as investigated.
Methods: PTFE and ePET fabrics were incubated for 50 minutes in
olutions containing unlabeled siRNA, siGLO Red (DyLight-547 tagged)
ransfection indicator siRNA, or cholesterol-siRNA-DyLight-547. siRNA
as used without a transfection reagent or was complexed with JetPEI, a
ationic polymer. siRNA concentrations were measured before and after
abric incubation to determine total adsorption. In a different experiment,
PET samples were dipped into siGLO Red/PEI solutions once for 50
inutes or repeatedly, 10 times for 5 minutes each, with intermittent washes
n NaCl. Confocal microscopy was performed and red fluorescent density
etermined.
Results: Unlabeled siRNA was not adsorbed to fabrics unless com-
lexed with PEI, whereas siGLO Red and Chol-siRNA-DyLight547 had
ome affinity to the materials. Overall, siRNA adsorption to ePET and PTFE
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October 20111232 Abstractsincreased when siRNA was complexed with PEI. The amount of siRNA
adsorbed generally appeared greater in ePET than in PTFE fabrics. Repeated
dipping of ePET in siGLO Red/PEI solution significantly increased siRNA
adsorption vs single dipping.
Conclusions: siRNA adsorption to ePET and PTFE surfaces is signif-
icantly increased if the siRNA is complexed with PEI. Preliminary data in this
study suggest that siRNA adsorbs better to ePET than PTFE. Further,
repeated dipping of ePET additionally increased adsorption of siRNA to
fabric. Thus, coating of ePETwith siRNA/PEImay be amethod to improve
graft patency.
Integrin ß-1 Regulates Eph-B4–Mediated Vein Graft Adaptation
Kenneth R. Ziegler,1 Clinton D. Protack,1 Sammy D. Eghbalieh,2 Lynn S.
Model,1 Michael J. Collins,1 Xin Li,1 Caroline C. Jadlowiec,3 Akihito
Muto,4 Frank J. Giordano,1 Alan Dardik,1 1Yale University School of
Medicine, New Haven, Conn; 2St. Mary’s Hospital, Waterbury, Conn;
3University of Connecticut, Farmington, Conn; 4Mie University, Tsu City,
Japan
Introduction and objectives: Eph-B4, the receptor tyrosine kinase
that serves as the embryonic venous fate determinant, is decreased in
association with the successful adaptation of surgical vein grafts to the
arterial environment. Stimulation of Eph-B4 recovers the native phenotype.
However, the Ephrin-B2 protein, the juxtacrine ligand for Eph-B4, is not
expressed in veins; as such, the adult physiologic controller of Eph-B4 is
unknown. We explored whether the mechanosensitive integrin--1 mole-
cule is an upstream regulator of Eph-B4 signaling.
Methods: Eph-B4–positive endothelial cells and Eph-B4–negative
Cos cells transfected with wild-type or mutant W804A Eph-B4 were stim-
ulated with type I collagen and anti–integrin--1 activating antibody
(P4G11) and analyzed with Western blotting. Colocalization was deter-
mined using immunofluorescence. Unilateral external carotid artery ligation
was performed on heterozygous integrin--1 knockout (Het-B1-KO) mice.
Carotid arteries were examined on day 14 and jugular veins on days 1 and 7.
Veins from Het-B1-KO mice were placed as aortic interposition grafts into
wild-type mice and examined at day 21.
Results:Endothelial cells stimulated with collagen or P4G11 increased
Eph-B4 phosphorylation. Eph-B4 and integrin--1 colocalized on both
endothelial cells and wild-type Eph-B4 transfected Cos cells after stimula-
tion with collagen; mutant W804A Eph-B4 transfected cells were unable to
phosphorylate Eph-B4. Het-B1-KOmice that underwent unilateral ligation
of the external carotid showed aberrant vascular remodeling. Het-B1-KO
vein grafts showed approximately threefold increased neointimal thickening
compared with wild-type controls.
Conclusions: Integrin--1 is present on endothelial cells, responds to
hemodynamic forces, induces Eph-B4 signaling, and modifies vessel and
vein graft remodeling. These results connect hemodynamic forces to vein
graft adaptation through extracellular matrix interactions. Integrin--1 is an
upstream regulator of Eph-B4 signaling during vein graft adaptation and
may represent a novel therapeutic target with the potential to limit neointi-
mal hyperplasia in vein grafts.
Prior Contralateral Amputation Predicts Worse Outcomes For Lower
Extremity Bypasses in the Intact Limb
Donald T. Baril,1 Philip P. Goodney,2 William P. Robinson,1 Brian W.
Nolan,2 David H. Stone,2 Paul Bloch,3 YouFu Li,1 Jack L. Cronenwett,2
Andres Schanzer,1 1University of Massachuestts Medical School, Worcester,
Mass; 2DartmouthHitchcockMedical Center, Lebanon, NH; 3MaineMed-
ical Center, Portland, Me
Introduction and objectives: A history of a contralateral amputation
as a potential predictor of outcomes after lower extremity bypass (LEB) for
critical limb ischemia (CLI) has not been studied. We sought to determine if
a prior contralateral lower extremity amputation predicts worse outcomes in
patients undergoing LEB in the remaining intact limb.
Methods: All patients undergoing infrainguinal LEB for CLI between
2003 and 2010 within the Vascular Study Group of New England (VSGNE)
were reviewed. Patients were stratified by whether they had previously
undergone a contralateral amputation before LEB. Primary end points
included major amputation and graft occlusion at 1 year postoperatively.
Secondary end points included in-hospital major adverse events and death at
1 year.
Results: Of 2636 LEB procedures, 228 (8.6%) were performed in
patients who had undergone a prior contralateral amputation. Patients with
a prior amputation compared with those without were younger (66.5 vs
68.7; P .034) and were more likely to have congestive heart failure (24.9%
vs 16.3%; P  .002), hypertension (94.4% vs 85.4%, P  .015), renal
u
mnsufficiency (26.0% vs 13.8%, P .0002), and dependence on hemodialysis
13.6% vs 6.0%, P  .0002). These patients experienced increased in-
ospital major adverse events, including myocardial infarction, congestive
eart failure, deterioration in renal function, and respiratory complications
Table). Patients with prior contralateral amputation experienced increased
ates of graft occlusion and amputation at 1 year, but there was no difference
n mortality. Multivariable analysis showed prior contralateral amputation
as an independent predictor (odds ratio [95% confidence interval]) of
mputation (1.73 [1.06-2.83] P  .027) and graft occlusion (1.93 [1.39-
.68] P  .0001) at 1 year.
able.
No prior
contralateral
amputation
Previous
contralateral
amputation P value
ost-operative
complications
Any in-hospital major
adverse event
12.5% 19.0% 0.044
MI 4.2% 8.9% 0.002
Dysrhythmia 4.4% 6.5% 0.156
CHF 3.4% 6.1% 0.044
Change in renal function 4.7% 9.0% 0.006
Respiratory 2.3% 37.5% 0.034
ne-year complication
Graft occlusion 16.7% 37.5 0.0001
Amputation 6.7% 15.9% 0.0001
Mortality 10.4% 15.8% 0.160
Conclusions: Patients with prior contralateral amputations who pres-
nt with CLI in the intact limb represent an extremely high-risk population.
hen LEB is considered in this setting, physicians and patients should
xpect increased rates of perioperative adverse events, increased rates of
-year graft occlusion, and decreased rates of limb salvage compared with
atients who do not have a contralateral amputation.
ltrasound-Guided Angioplasty of Autogenous Arteriovenous Fistu-
as in the Office Setting
aniel R. Gorin,1 Lisa Perrino,1 Donna Potter,1,2 Tarik Z. Ali,3 1Cape Cod
ealthcare, Hyannis, Mass; 2Ross Medical School, Roseau, Dominica;
Saba University School of Medicine, Devens, Mass
Introduction and objectives: There has been an increasing awareness
f the superiority of native arteriovenous fistulas (AVFs) over prosthetic
rafts for dialysis access. Many AVFs fail to mature, however, and others
evelop stenosis while in use. There is growing experience in treating these
atients in the interventional suite with percutaneous balloon angioplasty.
hese procedures, however, are expensive and uncomfortable for the pa-
ients, are inconvenient for patients and physicians, and involve exposure to
adiation and intravenous contrast agents in patients who are often not on
ialysis. This study reviews our experience with ultrasound-guided angio-
lasty of AVFs in the office setting.
Methods: A retrospective review was performed of all patients treated
n our practice with ultrasound-guided AVF angioplasty from May 2009 to
pril 2011. The need for intervention was determined by examination and
uplex ultrasound imaging. All patients referred to the practice with failing
r nonmaturing AVFs were treated in the office under ultrasound guidance,
nless a central venous stenosis was suspected. All procedures were per-
ormed with local anesthesia by a single surgeon, and ultrasound scans
efore, during, and after the procedure ultrasounds were performed in a
ingle vascular laboratory.
Results: The study included 30 patients with 31 AVFs who underwent
5 interventions: 48 for AVFs failing to mature and 7 for stenosis in
unctioning AFVs. Patency at 90 days was 93%. Overall complication rate
as 11%. In two patients, a proximal stenosis could not be crossed, of which
ne required surgical revision and one refused further treatment and throm-
osed. There were four peri-AVF hematomas, and three of these resulted in
FV thrombosis. No patients required hospitalization or urgent surgical
ntervention, and functional fistula was achieved in 85% of patients treated
or AVF failing to mature.
Conclusions: AVF intervention can be performed safely and effectively
nder ultrasound guidance in the office setting and is a valuable tool in the
anagement of dialysis access patients.
